Yi Xiang

2.5k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Yi Xiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yi Xiang has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Yi Xiang's work include Lung Cancer Treatments and Mutations (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers) and Bone Tissue Engineering Materials (5 papers). Yi Xiang is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Electrospun Nanofibers in Biomedical Applications (5 papers) and Bone Tissue Engineering Materials (5 papers). Yi Xiang collaborates with scholars based in China, United States and Finland. Yi Xiang's co-authors include Wenguo Cui, Lianfu Deng, Ruoyu Cheng, Wanghua Gong, Keqiang Chen, Tao Jiang, Yan Wang, Caicun Zhou, Yunpeng Liu and Zhe Yang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Biomaterials.

In The Last Decade

Yi Xiang

58 papers receiving 2.0k citations

Hit Papers

Investigating Novel Resistance Mechanisms to Third-Genera... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
    2018 390 citations Zhe Yang, Nong Yang et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Xiang China 25 602 522 501 413 354 59 2.0k
Akihiko Sano Japan 30 1.3k 2.2× 375 0.7× 393 0.8× 329 0.8× 357 1.0× 151 2.7k
Di Shi China 21 584 1.0× 656 1.3× 779 1.6× 454 1.1× 379 1.1× 44 2.1k
Bo Jia China 28 991 1.6× 281 0.5× 283 0.6× 332 0.8× 180 0.5× 135 2.3k
Christian Gorzelanny Germany 28 604 1.0× 367 0.7× 195 0.4× 455 1.1× 451 1.3× 64 2.8k
Phil Stephens United States 30 1.0k 1.7× 842 1.6× 803 1.6× 285 0.7× 237 0.7× 121 3.6k
Seong Keun Kwon South Korea 26 261 0.4× 517 1.0× 371 0.7× 367 0.9× 317 0.9× 97 1.8k
Yuan Yang China 21 400 0.7× 220 0.4× 375 0.7× 238 0.6× 337 1.0× 76 1.7k
Jiajü Lü China 28 651 1.1× 195 0.4× 177 0.4× 393 1.0× 520 1.5× 96 2.0k
Tatiana P. Ugarova United States 35 861 1.4× 826 1.6× 146 0.3× 415 1.0× 321 0.9× 79 3.4k
Viktoria Weber Austria 28 1.2k 1.9× 202 0.4× 188 0.4× 381 0.9× 255 0.7× 85 2.6k

Countries citing papers authored by Yi Xiang

Since Specialization
Citations

This map shows the geographic impact of Yi Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xiang more than expected).

Fields of papers citing papers by Yi Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xiang. The network helps show where Yi Xiang may publish in the future.

Co-authorship network of co-authors of Yi Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xiang. A scholar is included among the top collaborators of Yi Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xiang. Yi Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Chao, Bin Qin, Jingyu Zhang, et al.. (2024). Increased brain volume in the early phase of aneurysmal subarachnoid hemorrhage leads to delayed cerebral ischemia. Frontiers in Surgery. 11. 1467154–1467154. 1 indexed citations
2.
Chen, Yuanlin, et al.. (2024). A novel image encryption method based on improved two-dimensional logistic mapping and DNA computing. Frontiers in Physics. 12. 3 indexed citations
3.
Luo, Lifeng, Ling Zhou, Ziwei Xu, et al.. (2024). Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities. Cancer Cell International. 24(1). 84–84. 1 indexed citations
4.
Yang, Jin, Fang Liu, Ran Zeng, et al.. (2024). The predict factors and clinical prognosis value of immune-related pneumonia of receiving PD-1 inhibitor in advanced non-small cell lung cancer: A retrospective study. International Immunopharmacology. 142(Pt B). 113140–113140. 4 indexed citations
5.
Zhang, Chengzhi, et al.. (2023). Automatic recognition and classification of future work sentences from academic articles in a specific domain. Journal of Informetrics. 17(1). 101373–101373. 7 indexed citations
6.
Zhou, Ling, Yi Xiang, Zijun Qian, et al.. (2023). The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC. Open Life Sciences. 18(1). 20220533–20220533. 2 indexed citations
7.
Li, Jin, Weiwei Hu, Xiaorong Li, et al.. (2022). Characterization of a Type VI Secretion System vgrG2 Gene in the Pathogenicity of Burkholderia thailandensis BPM. Frontiers in Microbiology. 12. 811343–811343. 3 indexed citations
8.
Bao, Zhiyao, Lifeng Luo, Tian Xu, et al.. (2022). Risk factors and prognostic role of renal adverse event in patients receiving immune checkpoint inhibitor therapy: analysis of data from a retrospective cohort study. Annals of Translational Medicine. 10(18). 967–967. 5 indexed citations
9.
10.
Wang, Yue, Yaguang Weng, Li X, et al.. (2021). Dihydrotanshinone I inhibits aortic valve interstitial cell calcification via the SMAD1/5/8/NF-κB/ERK pathway. Biomedicine & Pharmacotherapy. 139. 111674–111674. 8 indexed citations
11.
Zeng, Ran, Fang Liu, Jin Yang, et al.. (2021). PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients. Frontiers in Immunology. 12. 724443–724443. 50 indexed citations
12.
Zeng, Ran, Lifeng Luo, Zhiyao Bao, et al.. (2021). EGFR/BRAF/MEK co-inhibition for EGFR-mutated lung adenocarcinoma patients with an acquired BRAFV600E mutation: a case report and review of literature. Cancer Drug Resistance. 4(4). 1019–1027. 6 indexed citations
13.
Yang, Zhe, Nong Yang, Qiuxiang Ou, et al.. (2018). Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients. Clinical Cancer Research. 24(13). 3097–3107. 390 indexed citations breakdown →
14.
Yoshimura, Teizo, Mairi H McLean, Amiran Dzutsev, et al.. (2018). The Antimicrobial Peptide CRAMP Is Essential for Colon Homeostasis by Maintaining Microbiota Balance. The Journal of Immunology. 200(6). 2174–2185. 62 indexed citations
15.
Zhang, Jing, et al.. (2018). Monitoring antiangiogenesis of bevacizumab in zebrafish. Drug Design Development and Therapy. Volume 12. 2423–2430. 24 indexed citations
16.
Chen, Wei, Jian Zhou, Andrew D. Lerner, et al.. (2017). A Comparison of Different Training Methods in the Successful Learning of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. Respiration. 93(5). 319–326. 3 indexed citations
17.
18.
Chen, Keqiang, Yi Xiang, Jiaqiang Huang, et al.. (2014). The Formylpeptide Receptor 2 (Fpr2) and Its Endogenous Ligand Cathelin-related Antimicrobial Peptide (CRAMP) Promote Dendritic Cell Maturation. Journal of Biological Chemistry. 289(25). 17553–17563. 31 indexed citations
19.
Xiang, Yi, Qiaoli Li, Jiawei Xu, et al.. (2012). Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population. Molecular Human Reproduction. 19(3). 153–159. 31 indexed citations
20.
Chen, Keqiang, Yi Xiang, Xiaohong Yao, et al.. (2011). The active contribution of Toll-like receptors to allergic airway inflammation. International Immunopharmacology. 11(10). 1391–1398. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiko Sano Breakdown of academic impact, for papers by Di Shi Breakdown of academic impact, for papers by Bo Jia Breakdown of academic impact, for papers by Christian Gorzelanny Breakdown of academic impact, for papers by Phil Stephens Breakdown of academic impact, for papers by Seong Keun Kwon Breakdown of academic impact, for papers by Yuan Yang Breakdown of academic impact, for papers by Jiajü Lü Breakdown of academic impact, for papers by Tatiana P. Ugarova Breakdown of academic impact, for papers by Viktoria Weber
Rankless by CCL
2026